US Stock MarketDetailed Quotes

AYTU Aytu BioPharma

Watchlist
  • 1.5500
  • +0.0418+2.77%
Trading Nov 22 10:34 ET
9.53MMarket Cap-1013P/E (TTM)

Aytu BioPharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Sep 30, 2024
(FY)Jun 30, 2024
(Q4)Jun 30, 2024
(Q3)Mar 31, 2024
(Q2)Dec 31, 2023
(Q1)Sep 30, 2023
(FY)Jun 30, 2023
(Q4)Jun 30, 2023
(Q3)Mar 31, 2023
(Q2)Dec 31, 2022
Total revenue
-6.98%16.57M
-24.58%81M
-41.51%17.98M
-20.85%17.99M
-12.73%22.93M
-35.57%17.82M
11.10%107.4M
11.96%30.73M
-6.06%22.73M
13.64%26.28M
Operating revenue
-6.98%16.57M
-24.58%81M
-41.51%17.98M
-20.85%17.99M
-12.73%22.93M
-35.57%17.82M
11.10%107.4M
11.96%30.73M
-6.06%22.73M
13.64%26.28M
Cost of revenue
-3.98%4.59M
-35.20%26.42M
-50.12%6.07M
-36.94%6.3M
-25.09%6.73M
-50.34%4.78M
-8.15%40.77M
-3.47%12.17M
-13.23%9.99M
-17.00%8.99M
Gross profit
-8.08%11.99M
-18.08%54.59M
-35.87%11.91M
-8.24%11.69M
-6.30%16.2M
-27.70%13.04M
27.44%66.63M
25.08%18.56M
0.45%12.74M
40.60%17.29M
Operating expense
-12.76%12.13M
-27.21%57.48M
-14.73%13.44M
-36.86%13.91M
-35.59%13.84M
-29.36%13.91M
-10.66%78.96M
-28.21%15.76M
-0.50%22.04M
-8.93%21.49M
Selling and administrative expenses
-12.93%10.78M
-29.40%49.47M
-21.33%11.09M
-39.99%11.99M
-35.33%12.02M
-28.91%12.39M
0.28%70.08M
-18.97%14.1M
15.10%19.98M
5.48%18.58M
-Selling and marketing expense
-7.09%5.66M
-34.96%26.96M
-19.68%6.41M
-48.85%6.55M
-37.73%6.58M
-39.71%6.09M
7.06%41.45M
-20.28%7.98M
31.42%12.8M
9.32%10.56M
-General and administrative expense
-18.59%5.13M
-21.36%22.51M
-23.49%4.68M
-24.17%5.44M
-32.17%5.44M
-14.03%6.3M
-8.14%28.63M
-17.19%6.11M
-5.76%7.18M
0.82%8.02M
Research and development costs
-28.40%426K
-31.84%2.79M
124.52%1.04M
-27.69%619K
-69.36%524K
-44.08%595K
-67.66%4.1M
-85.71%465K
-73.92%856K
-61.79%1.71M
Depreciation amortization depletion
-0.32%921K
8.86%5.21M
9.04%1.3M
8.76%1.3M
8.51%1.3M
-22.81%924K
-18.07%4.79M
-7.94%1.2M
-20.35%1.2M
-20.40%1.2M
-Depreciation and amortization
-0.32%921K
8.86%5.21M
9.04%1.3M
8.76%1.3M
8.51%1.3M
-22.81%924K
-18.07%4.79M
-7.94%1.2M
-20.35%1.2M
-20.40%1.2M
Operating profit
83.16%-146K
76.57%-2.89M
-154.43%-1.53M
76.11%-2.22M
156.38%2.36M
47.55%-867K
65.85%-12.33M
139.54%2.81M
1.77%-9.29M
62.87%-4.19M
Net non-operating interest income expense
22.53%-994K
3.45%-4.79M
-1.28M
-4.96M
Non-operating interest expense
-22.53%994K
-3.45%4.79M
----
----
----
--1.28M
--4.96M
----
----
----
Other net income (expense)
149.56%2.64M
-2,753.53%-6.4M
891.75%2.4M
-120.17%-422K
29.76%-1.76M
-659.14%-5.32M
100.33%241K
96.63%-303K
104.77%2.09M
-872.76%-2.5M
Gain on sale of security
148.76%2.88M
-183.54%-4M
206.48%1.46M
-60.47%1.02M
-141.13%-577K
-369.60%-5.91M
198.63%4.79M
-185.24%-1.37M
36,857.14%2.57M
--1.4M
Special income (charges)
---784K
37.52%-2.96M
-2.84%-2.72M
-133.24%-244K
--0
--0
93.57%-4.74M
73.17%-2.64M
101.67%734K
---2.68M
-Less：Restructuring and merger&acquisition
--784K
344.07%2.37M
556.13%2.12M
133.24%244K
--0
--0
41.45%-969K
52.01%-465K
38.94%-734K
--75K
-Less:Impairment of capital assets
----
----
----
--0
----
----
----
----
--0
----
-Less:Other special charges
----
--594K
----
----
----
----
----
----
----
----
-Write off
----
--0
----
----
--0
----
-40.92%5.71M
----
----
--2.6M
Other non- operating income (expenses)
-7.19%542K
208.70%568K
-1.62%3.65M
1.65%-1.2M
3.99%-1.18M
153.87%584K
124.31%184K
--3.71M
---1.22M
-377.82%-1.23M
Income before tax
120.05%1.5M
17.45%-14.08M
-59.63%-3.92M
63.31%-2.64M
109.08%608K
-966.05%-7.47M
84.34%-17.05M
84.73%-2.46M
86.49%-7.2M
42.06%-6.69M
Income tax
405K
1.77M
695K
245K
828K
0
0
0
0
0
Net income
118.15%1.47M
7.08%-15.84M
-87.91%-4.62M
59.90%-2.89M
96.71%-220K
-1,058.35%-8.12M
84.33%-17.05M
84.73%-2.46M
86.49%-7.2M
42.04%-6.69M
Net income continuous Operations
114.63%1.09M
7.08%-15.84M
-87.91%-4.62M
59.90%-2.89M
96.71%-220K
-966.05%-7.47M
84.33%-17.05M
84.73%-2.46M
86.49%-7.2M
42.04%-6.69M
Net income discontinuous operations
158.89%381K
----
----
----
----
---647K
----
----
----
----
Minority interest income
Net income attributable to the parent company
118.15%1.47M
7.08%-15.84M
-87.91%-4.62M
59.90%-2.89M
96.71%-220K
-1,058.35%-8.12M
84.33%-17.05M
84.73%-2.46M
86.49%-7.2M
42.04%-6.69M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
118.15%1.47M
7.08%-15.84M
-87.91%-4.62M
59.90%-2.89M
96.71%-220K
-1,058.35%-8.12M
84.33%-17.05M
84.73%-2.46M
86.49%-7.2M
42.04%-6.69M
Basic earnings per share
116.22%0.24
44.03%-2.86
-38.98%-0.82
73.06%-0.52
98.14%-0.04
-428.57%-1.48
93.10%-5.11
93.98%-0.59
94.62%-1.93
75.40%-2.15
Diluted earnings per share
89.86%-0.15
44.03%-2.86
-38.98%-0.82
73.06%-0.52
98.14%-0.04
-428.57%-1.48
93.10%-5.11
93.98%-0.59
94.62%-1.93
75.40%-2.15
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
(Q1)Sep 30, 2024(FY)Jun 30, 2024(Q4)Jun 30, 2024(Q3)Mar 31, 2024(Q2)Dec 31, 2023(Q1)Sep 30, 2023(FY)Jun 30, 2023(Q4)Jun 30, 2023(Q3)Mar 31, 2023(Q2)Dec 31, 2022
Total revenue -6.98%16.57M-24.58%81M-41.51%17.98M-20.85%17.99M-12.73%22.93M-35.57%17.82M11.10%107.4M11.96%30.73M-6.06%22.73M13.64%26.28M
Operating revenue -6.98%16.57M-24.58%81M-41.51%17.98M-20.85%17.99M-12.73%22.93M-35.57%17.82M11.10%107.4M11.96%30.73M-6.06%22.73M13.64%26.28M
Cost of revenue -3.98%4.59M-35.20%26.42M-50.12%6.07M-36.94%6.3M-25.09%6.73M-50.34%4.78M-8.15%40.77M-3.47%12.17M-13.23%9.99M-17.00%8.99M
Gross profit -8.08%11.99M-18.08%54.59M-35.87%11.91M-8.24%11.69M-6.30%16.2M-27.70%13.04M27.44%66.63M25.08%18.56M0.45%12.74M40.60%17.29M
Operating expense -12.76%12.13M-27.21%57.48M-14.73%13.44M-36.86%13.91M-35.59%13.84M-29.36%13.91M-10.66%78.96M-28.21%15.76M-0.50%22.04M-8.93%21.49M
Selling and administrative expenses -12.93%10.78M-29.40%49.47M-21.33%11.09M-39.99%11.99M-35.33%12.02M-28.91%12.39M0.28%70.08M-18.97%14.1M15.10%19.98M5.48%18.58M
-Selling and marketing expense -7.09%5.66M-34.96%26.96M-19.68%6.41M-48.85%6.55M-37.73%6.58M-39.71%6.09M7.06%41.45M-20.28%7.98M31.42%12.8M9.32%10.56M
-General and administrative expense -18.59%5.13M-21.36%22.51M-23.49%4.68M-24.17%5.44M-32.17%5.44M-14.03%6.3M-8.14%28.63M-17.19%6.11M-5.76%7.18M0.82%8.02M
Research and development costs -28.40%426K-31.84%2.79M124.52%1.04M-27.69%619K-69.36%524K-44.08%595K-67.66%4.1M-85.71%465K-73.92%856K-61.79%1.71M
Depreciation amortization depletion -0.32%921K8.86%5.21M9.04%1.3M8.76%1.3M8.51%1.3M-22.81%924K-18.07%4.79M-7.94%1.2M-20.35%1.2M-20.40%1.2M
-Depreciation and amortization -0.32%921K8.86%5.21M9.04%1.3M8.76%1.3M8.51%1.3M-22.81%924K-18.07%4.79M-7.94%1.2M-20.35%1.2M-20.40%1.2M
Operating profit 83.16%-146K76.57%-2.89M-154.43%-1.53M76.11%-2.22M156.38%2.36M47.55%-867K65.85%-12.33M139.54%2.81M1.77%-9.29M62.87%-4.19M
Net non-operating interest income expense 22.53%-994K3.45%-4.79M-1.28M-4.96M
Non-operating interest expense -22.53%994K-3.45%4.79M--------------1.28M--4.96M------------
Other net income (expense) 149.56%2.64M-2,753.53%-6.4M891.75%2.4M-120.17%-422K29.76%-1.76M-659.14%-5.32M100.33%241K96.63%-303K104.77%2.09M-872.76%-2.5M
Gain on sale of security 148.76%2.88M-183.54%-4M206.48%1.46M-60.47%1.02M-141.13%-577K-369.60%-5.91M198.63%4.79M-185.24%-1.37M36,857.14%2.57M--1.4M
Special income (charges) ---784K37.52%-2.96M-2.84%-2.72M-133.24%-244K--0--093.57%-4.74M73.17%-2.64M101.67%734K---2.68M
-Less：Restructuring and merger&acquisition --784K344.07%2.37M556.13%2.12M133.24%244K--0--041.45%-969K52.01%-465K38.94%-734K--75K
-Less:Impairment of capital assets --------------0------------------0----
-Less:Other special charges ------594K--------------------------------
-Write off ------0----------0-----40.92%5.71M----------2.6M
Other non- operating income (expenses) -7.19%542K208.70%568K-1.62%3.65M1.65%-1.2M3.99%-1.18M153.87%584K124.31%184K--3.71M---1.22M-377.82%-1.23M
Income before tax 120.05%1.5M17.45%-14.08M-59.63%-3.92M63.31%-2.64M109.08%608K-966.05%-7.47M84.34%-17.05M84.73%-2.46M86.49%-7.2M42.06%-6.69M
Income tax 405K1.77M695K245K828K00000
Net income 118.15%1.47M7.08%-15.84M-87.91%-4.62M59.90%-2.89M96.71%-220K-1,058.35%-8.12M84.33%-17.05M84.73%-2.46M86.49%-7.2M42.04%-6.69M
Net income continuous Operations 114.63%1.09M7.08%-15.84M-87.91%-4.62M59.90%-2.89M96.71%-220K-966.05%-7.47M84.33%-17.05M84.73%-2.46M86.49%-7.2M42.04%-6.69M
Net income discontinuous operations 158.89%381K-------------------647K----------------
Minority interest income
Net income attributable to the parent company 118.15%1.47M7.08%-15.84M-87.91%-4.62M59.90%-2.89M96.71%-220K-1,058.35%-8.12M84.33%-17.05M84.73%-2.46M86.49%-7.2M42.04%-6.69M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 118.15%1.47M7.08%-15.84M-87.91%-4.62M59.90%-2.89M96.71%-220K-1,058.35%-8.12M84.33%-17.05M84.73%-2.46M86.49%-7.2M42.04%-6.69M
Basic earnings per share 116.22%0.2444.03%-2.86-38.98%-0.8273.06%-0.5298.14%-0.04-428.57%-1.4893.10%-5.1193.98%-0.5994.62%-1.9375.40%-2.15
Diluted earnings per share 89.86%-0.1544.03%-2.86-38.98%-0.8273.06%-0.5298.14%-0.04-428.57%-1.4893.10%-5.1193.98%-0.5994.62%-1.9375.40%-2.15
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data